References
- COVID Live - Coronavirus Statistics - Worldometer. Available from: https://www.worldometers.info/coronavirus/. Accessed December 6, 2022.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi:10.1001/JAMA.2020.2648
- Guan W, Ni Z, Hu YY, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/nejmoa2002032
- Alene M, Yismaw L, Assemie MA, et al. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: a systematic review and meta-analysis. PLoS One. 2021;16:e0249090. doi:10.1371/JOURNAL.PONE.0249090
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–481. doi:10.1016/S2213-2600(20)30079-5
- Aziz S, Arabi YM, Alhazzani W, et al. Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med. 2020;46:1303–1325. doi:10.1007/S00134-020-06092-5
- Larsson E, Brattström O, Agvald-öhman C, et al. Characteristics and outcomes of patients with COVID-19 admitted to ICU in a tertiary hospital in Stockholm, Sweden. Acta Anaesthesiol Scand. 2021;65:76–81. doi:10.1111/AAS.13694
- Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–1581. doi:10.1001/JAMA.2020.5394
- Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–1770. doi:10.1016/S0140-6736(20)31189-2
- Sukrisman L, Sinto R, Priantono D. Hematologic profiles and correlation between absolute lymphocyte count and neutrophil/lymphocyte ratio with markers of inflammation of COVID-19 in an Indonesian national referral hospital. Int J Gen Med. 2021;14:6919–6924. doi:10.2147/IJGM.S337440
- Ali HS, Ananthegowda DC, Ebrahim EMA, et al. Neutrophil-to-lymphocyte ratio as a predictor of clinical outcomes in critically ill COVID-19 patients: a retrospective observational study. Heal Sci Rep. 2022:5. doi:10.1002/HSR2.844
- Mobarki AA, Dobie G, Saboor M, et al. MPR and NLR as prognostic markers in ICU-admitted patients with COVID-19 in Jazan, Saudi Arabia. Infect Drug Resist. 2021;14:4859–4864. doi:10.2147/IDR.S342259
- Meng L, Qiu H, Wan L, et al. Intubation and Ventilation amid the COVID-19 outbreak: Wuhan’s experience. Anesthesiology. 2020;132:1317–1332. doi:10.1097/ALN.0000000000003296
- Al-Otaiby M, Almutairi KM, Vinluan JM, et al. Demographic characteristics, comorbidities, and length of stay of COVID-19 patients admitted into intensive care units in Saudi Arabia: a nationwide retrospective study. Front Med. 2022;9. doi:10.3389/FMED.2022.893954
- Soriano MC, Vaquero C, Ortiz-Fernández A, et al. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J Infect. 2021;82:e20. doi:10.1016/J.JINF.2020.09.010
- Alqahtani A, Alamer E, Mir M, et al. Bacterial coinfections increase mortality of severely ill COVID-19 patients in Saudi Arabia. Int J Environ Res Public Health. 2022;19:2424. doi:10.3390/IJERPH19042424
- Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81:e6–e12. doi:10.1016/j.jinf.2020.04.002
- Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762–768. doi:10.1093/CID/CIAA248
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059. doi:10.1001/jama.2020.6775
- Quah P, Li A, Phua J, et al. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care. 2020;24:24. doi:10.1186/S13054-020-03006-1
- Nishikimi M, Rasul R, Sison CP, et al. Intubated COVID-19 predictive (ICOP) score for early mortality after intubation in patients with COVID-19. Sci Rep. 2021;11:1–11. doi:10.1038/s41598-021-00591-1
- Xia Y, Ma H, Buckeridge DL, et al. Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): a population-based cohort study of the first three epidemic waves. Int J Infect Dis. 2022;121:1–10. doi:10.1016/J.IJID.2022.04.048
- Sayed AA, Allam AA, Sayed AI, et al. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: a case-control retrospective multicenter study. Saudi Med J. 2021;42:370–376. doi:10.15537/SMJ.2021.42.4.20200818
- Feng Y, Ling Y, Bai T, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med. 2020;201:1380–1388. doi:10.1164/RCCM.202002-0445OC
- Kreitmann L, Monard C, Dauwalder O, et al. Early bacterial co-infection in ARDS related to COVID-19. Intensive Care Med. 2020;46:1787. doi:10.1007/S00134-020-06165-5
- Huttner BDD, Catho G, Pano-Pardo JRR, et al. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26:808–810. doi:10.1016/j.cmi.2020.04.024
- Wilson R, Dowling RB, Jackson AD. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J. 1996;9:1523–1530. doi:10.1183/09031936.96.09071523
- Luo Y, Xie Y, Zhang W, et al. Combination of lymphocyte number and function in evaluating host immunity. Aging. 2019;11:12685–12707. doi:10.18632/AGING.102595
- Rawson TM, Moore LSPP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71:2459–2468. doi:10.1093/CID/CIAA530
- Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–275. doi:10.1016/j.jinf.2020.05.046
- Silva DL, Lima CM, Magalhães VCR, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. J Hosp Infect. 2021;113:145–154. doi:10.1016/J.JHIN.2021.04.001
- He S, Liu W, Jiang M, et al. Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: a multi-center study. PLoS One. 2021;16:e0249668. doi:10.1371/JOURNAL.PONE.0249668
- Macvane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med. 2017;32:25–37. doi:10.1177/0885066615619895
- Sharifipour E, Shams S, Esmkhani M, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis. 2020;20:1–7. doi:10.1186/S12879-020-05374-Z/TABLES/1